Transcriptional Regulation of the Human MGP Promoter: Identification of Downstream Repressors
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252312597 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Helena Caiado und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center of Marine Sciences (CCMAR), University of Algarve, 8005-139 Faro, Portugal. Hauptthemen laut MEDLINE: Promoter Regions, Genetic, Matrix Gla Protein, Extracellular Matrix Proteins, YY1 Transcription Factor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, Portuguese Science and Technology Foundation (FCT), FCT.
Abstract (Originalsprache)
Matrix Gla protein (MGP) is a vitamin K-dependent γ-carboxylated protein that was initially identified as a physiological inhibitor of ectopic calcification, primarily affecting cartilage and the vascular system. Mutations in the MGP gene were found to be responsible for the Keutel syndrome, a condition characterized by abnormal calcifications in the cartilage, lungs, brain, and vascular system. MGP has been shown to be dysregulated in several tumors, including cervical, ovarian, urogenital, and breast cancers. Using bioinformatic approaches, transcription factor binding sites (TFBSs) containing CpG dinucleotides were identified in the MGP promoter, including those for YY1, GATA1, and C/EBPα. We carried out functional tests using transient transfections with a luciferase reporter assay, primarily for the transcription factors YY1, GATA1, C/EBPα, and RUNX2. By co-transfection analysis, we found that YY1, GATA1, and C/EBPα repressed the MGP promoter. Furthermore, the co-transfection with RUNX2 activated the MGP promoter. In addition, MGP expression is negatively or positively correlated with the studied TFs’ expression levels in several cancer types. This study provides novel insights into MGP regulation by demonstrating that YY1, GATA1, and C/EBPα are negative regulators of the MGP promoter, and DNA methylation may influence their activity. The dysregulation of these mechanisms in cancer should be further elucidated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Marine Sciences (CCMAR), University of Algarve, 8005-139 Faro, Portugal.
- Faculty of Medicine and Biomedical Sciences, University of Algarve, 8005-139 Faro, Portugal.
- Algarve Biomedical Center, University of Algarve, 8005-139 Faro, Portugal.
ORCID-Profile: M Leonor Cancela, Natércia Conceição
Förderung
- Fundação para a Ciência e Tecnologia
- Portuguese Science and Technology Foundation (FCT)
- FCT
Zitieren
APA
Caiado, H., Cancela, M. L., & Conceição, N. (2024). Transcriptional Regulation of the Human MGP Promoter: Identification of Downstream Repressors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312597
Vancouver
Caiado H, Cancela ML, Conceição N. Transcriptional Regulation of the Human MGP Promoter: Identification of Downstream Repressors. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312597
BibTeX
@article{Caiado2024,
author = {Caiado, Helena and Cancela, M Leonor and Conceição, Natércia},
title = {Transcriptional Regulation of the Human MGP Promoter: Identification of Downstream Repressors},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252312597}
}
EUVIMED